Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry
  1. WHRI
  2. People
  3. Academic staff
  4. Items

Professor Roger Corder

Roger

Emeritus Professor of Experimental Therapeutics

Centre: Translational Medicine and Therapeutics

Email: r.corder@qmul.ac.uk
Telephone: +44(0) 20 7882 8109

Profile

Roger Corder obtained a BSc in pharmacy at the University of Portsmouth. After qualifying as a pharmacist in 1978 he embarked on a career in research through positions in Endocrinology and Chemical Pathology at the Medical College of St. Bartholomew’s Hospital. He obtained an MSc in Pharmacology from the University of East London in 1981, and was awarded a PhD in 1986 from the University of London for his studies of neuropeptide Y. He undertook research for five years in the Department of Medicine in Geneva, Switzerland before returning to London in 1991 to take up a position of senior scientist leading endothelin research at the William Harvey Research Institute with Sir John Vane. He became Professor of Experimental Therapeutics in 2000. He is author of The Wine Diet, a best selling book published in more than 25 countries worldwide since 2006. Since 2000 he has been chairman of the management committee of the William Harvey Research Foundation.

Research

Group members

  • Research staff: Noorafza Khan, Elizabeth Wood
  • PhD students: Jale Yuzugulen
Experimental Therapeutics

Research is focused on the closely linked areas of diabetes and coronary heart disease.

This has three main goals: 
  1. Identification of biomarkers of disease for the early diagnosis of patients before symptoms develop, and which also respond to treatment so that they can be used as surrogate outcome measures in clinical trials.
  2. Clinical trials of dietary polyphenols to develop an evidence-based approach to improving vascular health or reducing diabetes through optimised foods and nutraceutical products.
  3. Characterisation of cellular and molecular actions of dietary polyphenols in order to define targets for future drug development.

Publications

    Sponsors

    Collaborators

    Internal

    Back to top